Standard Family Office’s Sarepta Therapeutics SRPT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-4,859	Closed	-$378K	–	460
2021 Q2	$378K	Buy	4,859 +2,314	+91%	+$180K	0.08%	103
2021 Q1	$190K	Buy	2,545 +1,767	+227%	+$132K	0.04%	131
2020 Q4	$133K	Buy	+778	New	+$133K	0.03%	163